Integral Molecular News

Potent and Efficacious Inhibition of CXCR2 Signaling by Biparatopic Nanobodies Combining Two Distinct Modes of Action

BRADLEY ET AL. 2015. MOL PHARMACOL (87):251–262.

Read More

Upcoming Events

 
Antibody Engineering & Therapeutics
12/4 – 12/8 | San Diego, California